Series B funding round for Colossal Biosciences raising $160M in January 2023
Series B funding round for Colossal Biosciences raising $160M in January 2023
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Non Profit | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Sahil Lavingia | |
| Angel | Jeff Bezos | |
| Angel | Victor L. Vescovo | |
| Angel | Shervin Pishevar | |
| Angel | Jeffrey Wilke | |
| Angel | Sahin Boydas | |
| Angel | Elia Montanari | |
| Angel | Thomas Tull | |
| Angel | Mark McDonnell |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$615M
Top Valuation
$10.2B
Colossal Biosciences raised $160M in a Series B round.
The round was announced on 01/01/23.
The round was led by Thomas Tull.